Table 3.
Task | Placebo | Active | Overall F | Sex | THC | Sex by THC | ||
---|---|---|---|---|---|---|---|---|
Males (n=17) | Females (n=17) | Males (n=18) | Females (n=18) | |||||
UFOV 1 (msec) | 16 (0) | 16 (0) | 16.4(1.6) | 16 (0) | 0.96 | 0.94 | 0.94 | 0.94 |
UFOV 2 (msec) | 16.0 (0) | 16.8 (3.4) | 23.6 (17.1) | 28.9 (32.7) | 1.84 | 0.47 | 4.76* | 0.25 |
UFOV 3 (msec) | 68.3(39.1) | 63.2 (19.3) | 83.3 (56.4) | 73.8 (21.2) | 0.94 | 0.67 | 2.07 | 0.06 |
UFOV 4 (msec) | 154.0 (64.7) | 169.1 (50.1) | 214.3 (77.8) | 206.9 (62.6) | 3.54* | 0.06 | 10.05** | 0.53 |
Trails B-A | 29.1 (9.4) | 23.7 (10.6) | 42.5 (23.6) | 39.9 (15.0) | 5.17* | 1.05 | 14.75*** | 0.13 |
Trails B/A*100 | 2.4 (0.6) | 1.9 (0.5) | 2.7 (1.0) | 2.6 (0.7) | 2.94* | 2.25 | 6.20* | 0.88 |
Time Estimation | 0.03 (0.46) | 0.07 (0.46) | -0.44 (0.82) | -0.13 (0.58) | 2.42 | 1.42 | 5.05* | 0.85 |
Structure from Motion | 9.7 (2.9) | 9.8 (1.9) | 10.0 (2.6) | 10.9 (2.0) | 0.91 | 0.80 | 1.29 | 0.52 |
UFOV = Useful Field of View
p < 0.05
p < 0.01
p < 0.001